Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | HotStocks USA: +27 % bei CareMax, - 28 % bei MaxLinear | 3 | stock3.com | ||
Mo | CareMax Shares Are Up By More Than 200%: What You Need To Know | 3 | Benzinga.com | ||
09.07. | CareMax, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
24.06. | CareMax, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
14.06. | CareMax, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
13.05. | CareMax, Inc. - 10-Q/A, Quarterly Report | 2 | SEC Filings | ||
09.05. | CareMax Reports First Quarter 2024 Results | 146 | Business Wire | MIAMI--(BUSINESS WIRE)--CareMax, Inc. (NASDAQ: CMAX; CMAXW) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the... ► Artikel lesen | |
09.05. | CareMax, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
09.05. | CareMax, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
29.04. | CareMax, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
19.03. | CareMax, Inc. (CMAX) Q4 2023 Earnings Call Transcript | 2 | Insider Monkey | ||
19.03. | Earnings call: CareMax outlines strategic shifts amid sector headwinds | 1 | Investing.com | ||
18.03. | CareMax reports Q4 results | 1 | Seeking Alpha | ||
18.03. | CareMax Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
18.03. | CareMax Slips To Q4 Loss On Higher Charges, Weak Revenues; Explores Strategic Options | 2 | RTTNews | ||
18.03. | CareMax, Inc. - 8-K, Current Report | - | SEC Filings | ||
18.03. | CareMax Reports Fourth Quarter and Full Year 2023 Results | 144 | Business Wire | MIAMI--(BUSINESS WIRE)--CareMax, Inc. (NASDAQ: CMAX; CMAXW) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the... ► Artikel lesen | |
18.03. | CareMax, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | - | SEC Filings | ||
18.03. | CareMax, Inc. - 10-K, Annual Report | - | SEC Filings | ||
12.03. | Renalytix, CareMax, TC BioPharm among healthcare movers | 9 | Seeking Alpha |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
INTUITIVE SURGICAL | 407,00 | +0,12 % | Better Buy: Abbott Laboratories vs. Intuitive Surgical | ||
ROKU | 54,18 | -0,39 % | Why Roku Stock Was Slipping This Week | ||
ATOSSA THERAPEUTICS | 1,266 | -6,22 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer | SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences | NEW DELHI (dpa-AFX) - Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical... ► Artikel lesen | |
EMEIS | 13,230 | +1,21 % | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
QUIDELORTHO | 35,200 | -0,56 % | S&P Dow Jones Indices: Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 | NEW YORK, July 23, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600:
Avantor Inc. (NYSE:AVTR) will replace QuidelOrtho Corp.... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 1,588 | +1,15 % | Aktien New York Ausblick: Weitere Tech-Rekorde - Nasdaq 100 mit 20 000 Punkten | NEW YORK (dpa-AFX) - Nach dem Feiertag zur Wochenmitte dürften die US-Aktienmärkte am Donnerstag gut behauptet eröffnen. Dabei sollten die Technologiewerte - allen voran die Halbleiterbranche - an... ► Artikel lesen | |
VERU | 0,843 | -3,33 % | Veru Inc.: Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program | --Phase 2b clinical study of enobosarm in combination with semaglutide (Wegovy®*) for high quality weight loss is actively enrolling-- --Company assembles esteemed high quality weight loss Scientific... ► Artikel lesen | |
CENTENE | 65,00 | -3,46 % | ROUNDUP: Centene Backs FY24 Earnings View, Lifts Revenue Forecast | WASHINGTON (dpa-AFX) - Healthcare enterprise Centene Corp. (CNC), while reporting higher second-quarter results, on Friday maintained its fiscal 2024 earnings view, but lifted revenue forecast.In... ► Artikel lesen | |
NANO-X IMAGING | 8,590 | +9,29 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
PERSPECTIVE THERAPEUTICS | 13,780 | +1,03 % | Perspective Therapeutics, Inc.: Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results | ||
LANTHEUS | 104,00 | +0,14 % | Lantheus Holdings, Inc.: Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer's Disease | BEDFORD, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight... ► Artikel lesen | |
AMN HEALTHCARE SERVICES | 57,50 | +2,68 % | AMN Healthcare Services Inc. Q1 Profit Decreases, But Beats Estimates | WASHINGTON (dpa-AFX) - AMN Healthcare Services Inc. (AMN) revealed a profit for first quarter that decreased from the same period last year but beat the Street estimates.The company's bottom... ► Artikel lesen | |
OMNICELL | 26,800 | -0,74 % | Omnicell Announces First Quarter 2024 Results | FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy care delivery model, today... ► Artikel lesen | |
TEMPUS AI | 41,920 | +4,75 % | wO Börsenlounge: Eli Lilly | Tempus AI | BP & Rechenzentrenperle aus Schweden | Rechenzentren schießen wie Pilze aus dem Boden. Die Nachfrage ist groß, da KI-Modelle schließlich richtig viel Rechenpower brauchen. Die üblichen Verdächtigen sind wieder angesprungen. Eine Perle aus... ► Artikel lesen |